A new study has suggested that the routine screening for prostate cancer augments the risk of catching the disease much before it spreads to the parts of the body.
Ever since the year 1993, it has been seen that the screening with PSA blood test, used to detect a prostate protein has been very much in use. However, the test is considered o be as unreliable and not linked to a proven increase in survival, in the UK.
This study reportedly was more concerned about the risk of cancer spreading to other parts of the body, than the life expectancy linked with the screening. It has also been seen that if prostate cancer, somehow happens to reach this advanced stage, the disease becomes incurable.
This study involved 1,721 prostate cancer patients. All these patients had undergone some surgery or radiation therapy for the cure of the disease.
“Our study demonstrates that the PSA test is extremely valuable in catching the disease earlier and allowing men to live more productive lives after treatment”, said Study leader Chandana Reddy, from the Cleveland Clinic in Ohio.
A comparative study of the patients was carried out before and after the introduction of screening.